Topic: psoriasis
Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the release of the first National Psoriasis Victor Henschel BioBank DNA samples for use in re ... moreTreatment with narrow-band UV-B rays may increase serum levels of vitamin D in the wintertime while clearing psoriasis, according to a report in the August issue of Archives of Dermatology, one of the ... more
In a population-based cohort study, patients with psoriasis had an increased risk for depression, anxiety, and suicidality. Medscape Medical News ... more
Individuals with psoriasis appear to have an increased risk of depression, anxiety and suicidality, according to a report in the August issue of Archives of Dermatology, one of the JAMA/Archives journ ... more
Treatment with narrow-band UV-B rays may increase serum levels of vitamin D in the wintertime while clearing psoriasis, according to a report in the August issue of Archives of Dermatology, one of the ... more
Long-term study finds higher risk with regular brew, but not light beer or wine Source: HealthDay Related MedlinePlus Pages: Alcohol, Psoriasis, Women's Health ... more
Ultraviolet light therapy lessens the symptoms of psoriasis and simultaneously raises vitamin D levels, a new study shows. However, increased vitamin D is probably unrelated to light therapy's benefit ... more
Long-term study finds higher risk with regular brew, but not light beer or wine ... more
Unless it says light on the label, that frosty beer you drink may increase the risk of developing psoriasis, new research indicates. ... more
Individuals with psoriasis appear to have an increased risk of depression, anxiety and suicidality, according to a new study. ... more
Regular beer -- but not light beer or other types of alcohol -- appears to be associated with an increased risk of developing psoriasis, according to a new study. ... more
Treatment with narrow-band UV-B rays may increase serum levels of vitamin D in the wintertime while clearing psoriasis, according to a new study. ... more
Patients with psoriasis have a higher risk of developing depression or anxiety, and having suicidal feelings, says a report published today in Archives of Dermatology, a JAMA/Archives (Journal of the ... more
Women who drink beer regularly seem to have a higher risk of developing psoriasis, according to a study published in Archives of Dermatology, a JAMA/Archives journal. The link does not apply to light ... more
Treatment with narrow-band UV-B rays may increase serum levels of vitamin D in the wintertime while clearing psoriasis, according to a report in the August issue of Archives of Dermatology, one of the ... more
Results of a small prospective study suggest that adalimumab (Humira, Abbott) is an effective and safe treatment option for psoriasis patients who don't respond to etanercept (Enbrel, Amgen/Pfizer). ... more
The August issue of NIH News in Health is now available. Featured stories cover fitting more fiber into your day and living with psoriasis. Also, check out the health capsules and the featured Web si ... more
August is Psoriasis Awareness Month. Visit the psoriasis health topic page, which includes an interactive health tutorial. ... more
This fact sheet provides basic information about the herb feverfew #8212;common names, uses, potential side effects, and resources for more information. Originally a plant native to the Balkan mountai ... more
Among persons with psoriasis, those who reported being obese at age 18 had an increased risk of developing psoriatic arthritis, according to a report in the July 19 issue of Archives of Dermatology, o ... more
Among persons with psoriasis, those who reported being obese at age 18 had an increased risk of developing psoriatic arthritis, according to a report in the 19 July issue of Archives of Dermatology, o ... more
Among persons with psoriasis, those who reported being obese at age 18 had an increased risk of developing psoriatic arthritis, according to a report in the July 19 issue of Archives of Dermatology, o ... more
Among the most common forms of hair loss, and perhaps the most common autoimmune disease, alopecia areata affects 5.3 million in US NEW YORK Ā A team of investigators led by Columbia University Medic ... more
PhotoMedex, Inc. (Nasdaq: PHMD) announced that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC VelocityĀ® excimer laser in the treatment of gene ... more
Individuals treated for acne, psoriasis or another skin condition with vitamin A analogues (retinoids) do not appear to be at increased risk of fracture, according to a report in the May issue of Arch ... more
Person's age, lifestyle and condition's severity play a roleSource: HealthDay Related MedlinePlus Page: Psoriasis ... more
Person's age, lifestyle and condition's severity play a role ... more
New research promises to pry some long held secrets from one of humanity's oldest known diseases. Scientists have discovered how to parse the most troublesome cells behind the debilitating skin lesion ... more
New research published online in the Journal of the American Academy of Dermatology (JAAD) shows that treatment with STELARA(TM)(Black Triangle Drug) (ustekinumab) significantly improves symptoms of d ... more
A case-control study shows that patients treated for acne, psoriasis, or another skin condition with vitamin A analogues are not at increased risk for fracture. Medscape Medical News ... more
Dutch researchers found retinoids not linked to more broken bones Source: HealthDay Related MedlinePlus Pages: Acne, Fractures, Psoriasis ... more
Individuals treated for acne, psoriasis or another skin condition with vitamin A analogues (retinoids) do not appear to be at increased risk of fracture, according to a new report. ... more
Clinical Knowledge Summaries (CKS) has been updated in May 2010 for the following clinical areas: Baker s Cyst (new) Coeliac disease (new) Dupuytren s disease (new) Mastitis ( ... more
Clinical Knowledge Summaries (CKS) has been updated in May 2010 for the following clinical areas: Baker s Cyst (new) Coeliac disease (new) Dupuytren s disease (new) Mastitis ( ... more
Dutch researchers found retinoids not linked to more broken bones ... more
It #8217;s never easy being a snitch and a new study in The New England Journal of Medicine finds the process takes a heavy toll on personal and professional lives, since whistleblower cases last, on ... more
VBL Therapeutics today announced positive preclinical results evaluating VB-201 for the treatment of psoriasis. VB-201 is a first-in-class, orally administered immune response modifier expected to red ... more
Contact: Emily Butler emily_butler@urmc.rochester.edu 585-273-1757 University of Rochester Medical Center Natural supplement boasts excellent safety A widely and safely used plant extract acts as a no ... more
Diagnosed at age 2, the singer is teaming with health groups to bolster patient support ... more
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most efficacio ... more
Grammy Award-winning multi-platinum recording artist and psoriasis patient LeAnn Rimes is calling for people with psoriasis to pledge to better manage their disease as part of the awareness campaign " ... more
Fit in Your Skin ¢, a first-of-its-kind health and wellness program specifically designed for people living with psoriasis, is being introduced today through a collaborative effort between Centocor O ... more
Depression Psoriasis Asthma /div ... more
People who suffer from psoriasis may be at an increased risk of other serious medical conditions, including heart disease and cancer, studies show. ... more
Statin users with psoriasis showed a 64% reduction in psoriasis severity, whereas nonusers showed a 45% reduction in severity after the initiation of a new psoriasis medication. Medscape Medical New ... more
Skin ailment boosts odds for heart attack, stroke, and inflammation may be key, researchers say Source: HealthDay Related MedlinePlus Pages: Heart Diseases, Psoriasis, Stroke ... more
Psoriasis patients should be considered at increased cardiovascular risk and prioritized for earlier medical risk-factor intervention for heart disease, the authors of a new study say. Heartwire ... more
Skin ailment boosts odds for heart attack, stroke, and inflammation may be key, researchers say ... more
Children with psoriasis had a 25% higher risk of developing any psychiatric disorder, a 23% higher risk of developing depression, and a 62% higher risk of using tricyclic antidepressants. Medscape M ... more
Infliximab is effective, safe, and reasonably well tolerated in patients with plaque psoriasis who previously had a poor response to etanercept, according to results from the new PSUNRISE study. Med ... more
When the drug Enbrel stops working, people with psoriasis have two effective options, new research suggests. ... more
A study shows cholesterol-lowering statins may help treat psoriasis. ... more
Source: American Academy of Dermatology Related MedlinePlus Page: Psoriasis ... more
For the approximately 7.5 million Americans affected by psoriasis, the thick, red, scaly, itchy plaques it causes only scratch the surface when it comes to the overall implications of this disease. No ... more
For the approximately 7.5 million Americans affected by psoriasis, the thick, red, scaly, itchy plaques it causes only scratch the surface when it comes to the overall implications of this disease. No ... more
Medicated skin creams, spraysĀ and powders can be very effective at treating dermatological conditions #8211;if you can get the medicineĀ to stay on your skin. Drug delivery is a major challengeĀ in t ... more
Initial treatment with twice weekly etanercept (Enbrel), a tumour necrosis factor antagonist, achieves more rapid clearance of skin lesions than once weekly treatment in patients with active psoriasis ... more
Contact: Mick Kulikowski mick_kulikowski@ncsu.edu 919-515-8387 North Carolina State University In a surprising finding, researchers at North Carolina State University have discovered the critical impo ... more
People with severe forms of the inflammatory skin disease psoriasis are more likely to die of heart-related causes and stroke than those without the condition, new research shows. Source: Reuters Heal ... more
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive th ... more
Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treating pati ... more
Reaching a 90% improvement score was more common among those who received ustekinumab, but both drugs were able to achieve at least 50% improvement in all patients. Medscape Medical News ... more
Stelara tops Enbrel in head-to-head comparison and requires fewer injections, researchers say Source: HealthDay Related MedlinePlus Topics: Medicines, Psoriasis ... more
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce ab ... more
The 2010 OneMedForum, taking place through Jan. 14 in San Francisco, features presentations from over 100 emerging life science and healthcare companies. One company presenting at the conference is Sa ... more
A recently approved drug, Stelara, is more effective than a more established drug, Enbrel, in treating moderate to severe psoriasis, according to a new study. ... more
Stelara tops Enbrel in head-to-head comparison and requires fewer injections, researchers say ... more
VBL Therapeutics announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, ... more
InNexus Biotechnology Inc. (TSX.V: IXS) , a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL ¢) technology, announced ... more
Psoriasis, a chronic disease that causes red, raised patches of skin, is increasingly seen as a systemic disease with links to arthritis and cardiovascular disease. ... more
Scientists have drilled down on the molecular nitty-gritty that distinguishes the two most common forms of inflammatory skin disease, atopic eczema and psoriasis. The researchers say that the ability ... more
Researchers hope to harness mind's reaction to medication Source: HealthDay Related MedlinePlus Topic: Psoriasis ... more
Psoriasis, a chronic disease that causes red, raised patches of skin, is increasingly seen as a systemic disease with links to arthritis and cardiovascular disease. The December issue of Mayo Clinic W ... more
Researchers hope to harness mind's reaction to medication ... more
Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to an early study published ... more
Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to a new study. Early resul ... more
Celgene Corporation (NASDAQ:CELG) announced clinical data from an investigational Phase IIb, double-blind, placebo-controlled study of apremilast (CC-10004) in patients with moderate-to-severe plaque- ... more
A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time this week ... more
For our readers that may not have already seen this, here's Sen Harry Reid (D-BS) opining that Republicans who oppose ObamaCare are akin to folks that opposed an end to slavery, women's right to vote ... more
Contact: Tracy Vineis 617-914-6524 GCI Health CAMBRIDGE, Mass. December 7, 2009 Biogen Idec (NASDAQ: BIIB) today announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in ... more
Ten years of clinical trials have shown adalimumab to be safe for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, and juvenile idiopathi ... more
Provectus Announces Preliminary Phase 2 Data For PH-10 In Its Psoriasis And Atopic Dermatitis Trials
Provectus Pharmaceuticals, a company specializing in oncology and dermatological therapeutics, has announced preliminary Phase II data for its drug candidate to treat psoriasis and atopic dermatitis. ... more
Psoriasis High Blood Pressure Bipolar Disorder /div ... more
Neuherberg, November 20, 2009. Scientists of Helmholtz Zentrum Mnchen and the Center of Allergy and Environment (ZAUM) of Technische Universitt Mnchen have discovered a new type of immune cells - the ... more
A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time this week ... more
Beginning Thursday, Nov. 19, 2009, the International Psoriasis Council (IPC) will host its second symposium at Baylor University Medical Center in Dallas. The two-day conference brings together dermat ... more
A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time in new re ... more
Psoriasis Osteoporosis Hypertension /div ... more
A first-of-its-kind symposium has convened today that brings together U.S. and Latin American dermatologists in an effort to elevate the global understanding of psoriasis and its treatment. ... more
PhotoMedex, Inc. (Nasdaq: PHMD) a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009. ... more
Ragweed Allergy Atrial Fibrillation Psoriasis /div ... more
Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new g ... more
Source: American Academy of Dermatology Related MedlinePlus Topic: Psoriasis ... more
Persistent inflammation and the activation of the immune system is the key pathological mechanism affecting many long-term conditions, such as rheumatoid arthritis, psoriasis, ulcerative colitis, and ... more
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-1 ... more
Psoriasis Type 2 Diabetes High Blood Pressure /div ... more
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III ... more
After a long delay, Centocor Ortho Biotech #8217;s psoriasis drug Stelara has been approved by the U.S. Food and Drug Administration. Stelara is intended to treat moderate to severe plaque psoriasis, ... more
The U.S. Food and Drug Administration approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis. Plaque psoriasis is an immune system disorder tha ... more
The FDA has approved ustekinumab subcutaneous injection for the treatment of moderate to severe plaque psoriasis in adults. Medscape Medical News ... more
Helps block overproduction of skin cells ... more
"The Misperception That Clinical Trial Data Reflect Long-term Drug Safety" is the title of a commentary in this week's Archives of Dermatology. The authors focused on one particular drug - Raptiva ( ... more
The first genetic test for Psoriatic arthritis (PsA) is being launched today by PsoriasisDX, LLC, a subsidiary of molecular dermatology research and development innovator PharmaGenoma, Inc. PsA is a ... more
Enbrel (etanercept), Wyeth's biological treatment for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis, is now available as a new easy-to-use pre-filled auto-injector de ... more
Chronic inflammation represents the key pathogenic event of many diseases, autoimmune rheumatic diseases, such as psoriasis, inflammatory bowel diseases, asthma, multiple sclerosis, atherosclerosis, a ... more
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF ... more
A study shows that people with severe psoriasis have altered brain responses to expressions of disgust, a phenomenon that scientists believe might be an acquired coping mechanism. Medscape Medical N ... more
New research suggests that the brains of some psoriasis patients may adapt to cope with the body image and self-esteem issues that can accompany the skin disorder. ... more
People with psoriasis - an often distressing dermatological condition that causes lesions and red scaly patches on the skin - are less likely to react to looks of disgust by others than people without ... more
A new computational method has proven its usefulness in counting duplicated sequences in human genomes and in initially assessing their content. Duplicated segments have been linked with several types ... more
Nails are the tough flat structures that provide form and shape to the tips of fingers and toes. They improve grip of fine objects. Discoloured nails are a sign of allergic disorders, infections or d ... more
New research suggests that the brains of some psoriasis patients may adapt to cope with the body image and self-esteem issues that can accompany the skin disorder. ... more
A specific genetic region that has been increasingly identified as the strongest genetic link to psoriasis has an even more significant role in the chronic skin disease than has been suspected, medica ... more
People with psoriasis an often distressing dermatological condition that causes lesions and scaly patches on the skin are less likely to react to looks of disgust by others than people without ... more
First demonstration of clinical efficacy for novel class of resolvin therapeutics BEDFORD, MA August, 24, 2009 #8212; Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today ... more
Provectus Pharmaceuticals, Inc. (OTCBB:PVCT), a development-stage oncology and dermatology biopharmaceutical company, has added Mount Sinai School of Medicine as its second and final site for its expa ... more
Overactive Bladder Psoriasis (Ages 18-65) Alcoholism (Opiate Dependence) /div ... more
August is Psoriasis Awareness Month. Visit the psoriasis health topic page, which includes an interactive health tutorial. ... more
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has initiated a new Phase 2 clinical trial of PH-10 for psoriasis involving dai ... more
A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer's symptoms. ... more
Many of the approximately one million Canadians(i) living with psoriasis may be faced with physical or emotional challenges as they struggle with public misperceptions and stigmas of this painful, ch ... more
A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer's symptoms. ... more
July 7, 2009 - FasterCures today announced its support of Research Revolution, 23andMe's just launched effort that aims to change the way we learn about how genes and environment affect the causes and ... more
Psoriasis, a chronic skin disorder caused by the immune system, affects 1%-2% of white individuals. Although there are a number of treatments, the chronic recurrent nature of the disorder means more e ... more
Treatment with anti-tumor necrosis factor agents is recognized as a risk factor for tuberculosis in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondyl ... more
Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylos ... more
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from ... more
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from ... more
As well as being an independent risk factor for cardiovascular disease, psoriasis is also associated with an increased risk of cerebrovascular disease and peripheral arterial disease, a new case-contr ... more
The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, periphe ... more
Inflammation looks like common thread, researcher says. Source: HealthDay ... more
People with psoriasis may need to pay close attention to their cardiovascular risks, a new study shows. ... more
The Australian Government will subsidise new forms of several drugs already listed on the PBS and will extend the listing of Adalimumab as an alternative treatment for severe psoriasis. ... more
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such ... more
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed promising results in treating autoimmune disorders such ... more
A major challenge in treating autoimmune disorders has been suppressing inflammatory attacks on body tissues without generally suppressing immune function. Now, a drug from Chinese medicine shows pote ... more
A drug derived from an herb used in Chinese medicine for 2,000 years is the first to target specific cells overactive in rheumatoid arthritis, psoriasis, and other autoimmune diseases. ... more
PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as other products for dermatological applications, announced the availability ... more
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, has achieved yet another goal by completion of patients' enrollment in its phase II Psoriasis trial. Appr ... more
Smoking IBS (Irritable Bowel Syndrome) Psoriasis Cystic Fibrosis Attention Deficit/Hyperactivity Disorder (ADHD - Adults) Hyperte ... more
Vitamin D may slow the progressive decline in the ability to breathe that can occur in people with asthma as a result of human airway smooth muscle (HASM) proliferation, according to researchers at th ... more
In a randomized controlled trial, ultraviolet B phototherapy given at home or in an outpatient setting were equally safe and effective in the treatment of psoriasis, both clinically and for quality of ... more
UVB therapy at home is safe, effective and more convenient, researchers say. Source: HealthDay ... more
For patients with psoriasis, treatment with ultraviolet B (UVB) at home is as effective and as safe as conventional hospital based phototherapy, concludes a study published on bmj.com today. Patients ... more
For patients with psoriasis, treatment with ultraviolet B at home is as effective and as safe as conventional hospital based phototherapy, suggests a new study. ... more
Home treatment of the skin ailment psoriasis with ultraviolet light lamps is at least as safe and effective as conventional phototherapy at hospitals or clinics, according to new research. ... more
Abbott has announced new data showing that HUMIRAĀ® (adalimumab) is as effective in patients with moderate to severe psoriasis at 16 weeks with or without the concurrent use of topical therapy.1 The ... more
Ultraviolet light is a proven treatment for psoriasis, one of humanity's oldest known diseases. Sunshine can also beat back the chronic autoimmune disorder of the skin. But explaining light's therapeu ... more
In a prospective study of US female nurses, psoriasis was independently associated with an increased risk for diabetes and hypertension. Medscape Medical News ... more
Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a new article. ... more
A new Cochrane review finds that two commonly used topical treatments work best together to treat chronic psoriasis, but are not a cure. ... more
Scientists find that two commonly used topical treatments work best together to treat chronic psoriasis, but are not a cure. ... more
Gastroesophageal Reflux Disease (GERD) Migraine and Cluster Headaches Pain Irritable Bowel Syndrome (IBS) Psoriasis Atopic Dermat ... more
US scientists who followed 78,000 women for 14 years found that having psoriasis, an immune system condition that appears on the skin in the form of thick, red scaly patches, was linked to a hig ... more
US scientists who followed 78,000 women for 14 years found that having psoriasis, an immune system condition that appears on the skin in the form of thick, red scaly patches, was linked to a hig ... more
Researchers suspect chronic inflammation is common thread among all 3 conditions. Source: HealthDay ... more
Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology, one of the J ... more
Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology, one of the J ... more
In response to a study in JAMA's Archives of Dermatology indicating a link between psoriasis and an increased risk of diabetes and hypertension, Ellen Mason, Cardiac Nurse at the British Heart Foundat ... more
In response to a study in JAMA's Archives of Dermatology indicating a link between psoriasis and an increased risk of diabetes and hypertension, Ellen Mason, Cardiac Nurse at the British Heart Foundat ... more
Women who have the chronic skin condition psoriasis appear to be at higher risk of getting diabetes and high blood pressure, a new study shows. ... more
Chronic plaque psoriasis is the most common type of psoriasis and is characterised by redness, thickness and scaling. First line management of chronic plaque psoriasis is with topical treatments, incl ... more
Genentech, Inc. announced a phased voluntary withdrawal of the psoriasis drug RaptivaĀ® (efalizumab) from the U.S. market. The company's decision is based on the association of Raptiva with an increas ... more
Psoriatic arthritis affects about 11 percent of patients with psoriasis. Anti-tumor necrosis factor ĆĀ± (anti-TNFĆĀ±) agents, which block signaling molecules that induce inflammation, improve the sy ... more
Efalizumab (Raptiva), used for the treatment of psoriasis, will no longer be available in the United States because of the risk for progressive multifocal leukoencephalopathy. Medscape Medical News ... more
Drug manufacturer acts after link found to rare brain infection. Source: HealthDay ... more
Genentech on Wednesday announced the phased voluntary withdrawal of psoriasis drug Raptiva (efalizumab) from the US market "based on the association of [the drug] with an increased risk of progressive ... more
Genentech on Wednesday announced the phased voluntary withdrawal of psoriasis drug Raptiva (efalizumab) from the US market "based on the association of [the drug] with an increased risk of progressive ... more
Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of the product from the U.S. market. The company is taking thi ... more
Psoriatic arthritis affects about 11 percent of patients with psoriasis. Anti-tumor necrosis factor Ā± (anti-TNFĀ±) agents, which block signaling molecules that induce inflammation, improve the sympto ... more
Low-dose acitretin (a drug used to treat skin psoriasis) therapy appears to reduce nail psoriasis symptoms, according to a report in the March issue of Archives of Dermatology, one of the JAMA/Archive ... more
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the ... more
Data from the 2008 Psoriasis Patient Study from Consumer Health Sciences, were presented at the 67th Annual Meeting of the American Academy of Dermatology in San Francisco on March 10, 200 ... more
Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA "hotspots " that may reveal how genetic differences ... more
Source: American Academy of Dermatology ... more
A topical eye emulsion consisting of cyclosporine (a medication used to reduce transplant rejections or to treat arthritis and psoriasis) may be a cost-effective treatment for dry eye syndrome that do ... more
A topical eye emulsion consisting of cyclosporine (a medication used to reduce transplant rejections or to treat arthritis and psoriasis) may be a cost-effective treatment for dry eye syndrome that do ... more
Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA #8220;hotspots #8221; that may reveal how genetic difference ... more
Promius Pharma, LLC, has launched Scytera ¢ (coal tar) Foam 2% for the treatment of chronic psoriasis, a skin disease that affects approximately 7.5 million Americans according to The National Psoria ... more
Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA "hotspots" that may reveal how genetic differences among indi ... more
Patients with dermatological disease often find it difficult to participate in patient support groups.Online support options may be particularly helpful in these cases.MedPage Today reports a small st ... more
Medical News Today is pleased to announce the launch of a new Eczema / Psoriasis channel. The section will include news on skin dryness, recurring rashes, psoriatic plaques and psoriatic arthritis p ... more
According to Archives of Dermatology, psoriasis patients receive valuable educational, psychological and social support from online support communities. Archives of Dermatology is a JAMA (Journal of ... more
Psoriasis is associated with elevated leptin levels independently of obesity, metabolic syndrome or female gender, Taiwanese researchers report in the December issue of the Archives of Dermatology. ... more
Hello, everyone. We hope your weekend was refreshing, although we imagine there are some among you with sore backs after spending time shoveling snow. Nonetheless, this is a short week, so there will ... more
Experts are urging that patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease. ... more
The skin disease psoriasis has been associated with higher levels of the protein leptin, according to an article released on December 15, 2008 in Archives of Dermatology, one of the JAMA/Archives jo ... more
The skin disease psoriasis has been associated with higher levels of the protein leptin, according to an article released on December 15, 2008 in Archives of Dermatology, one of the JAMA/Archives jo ... more
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than pe ... more
Patients with the skin disease psoriasis appear more likely to have higher levels of leptin (a hormone produced by fat cells that may contribute to obesity and other metabolic abnormalities) than pe ... more
New data presented today at the 'Gene to Clinic' meeting taking place at the Royal College of Physicians in London, England, reinforce Enbrel's ability to clear skin in patients with psoriatic arthrit ... more
Psoriasis affects 2-3% of people in the UK and can create both physical and psychological distress. Psychological discomfort is made worse by the visible nature of the condition where ... more
Janssen-Cilag announced that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of adults with moderate to severe plaque psoriasis from the Europea ... more
Genentech, Inc. (NYSE: DNA) announced that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopath ... more
Janssen-Cilag announced today that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of moderate to severe plaque psoriasis from the European Commit ... more
Traditional Chinese therapy proved helpful in relieving skin scaling, hardening, study finds. Source: HealthDay ... more
A randomized controlled trial showed that topical indigo naturalis ointment treatment significantly reduced scaling and erythema without adverse events in patients with plaque-type psoriasis. Medsca ... more
The University of Alabama at Birmingham (UAB) Center for Education and Research on Therapeutics (CERTs) has won a $2.2 million federal grant to study the risks and benefits of a newer class of medicin ... more
Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephal ... more
Traditional Chinese therapy proved helpful in relieving skin scaling, hardening, study finds ... more